Browsing byAuthorDe Abreu Lourenco, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 26 to 45 of 55< previous   next >
Issue DateTitleAuthor(s)
2018-10-01Key considerations in reimbursement decision-making for multiple sclerosis drugs in AustraliaPhan, YHL; De Abreu Lourenco, R; Haas, M; van der Linden, N
2021-10-04Long-term health-related quality of life in young childhood cancer survivors and their parents.Fardell, JE; Wakefield, CE; De Abreu Lourenco, R; Signorelli, C; McCarthy, M; McLoone, J; Osborn, M; Gabriel, M; Anazodo, A; Alvaro, F; Lockwood, L; Walwyn, T; Skeen, J; Tillemans, R; Cohn, RJ; ANZCHOG Survivorship Group,
2021-02-03Managing low‐risk febrile neutropenia in children in the time of COVID‐19: What matters to parents and cliniciansHaeusler, GM; De Abreu Lourenco, R; Bakos, C; O'Brien, T; Slavin, MA; Clark, JE; McMullan, B; Borland, ML; Babl, FE; Krishnasamy, M; Vanevski, M; Thursky, KA; Hall, L
2023-01Men's perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review.Brown, A; Yim, J; Jones, S; Tan, A; Callander, E; Watt, K; De Abreu Lourenco, R; Pain, T
2022-01-01Men's preferences for image-guidance in prostate radiation therapy: A discrete choice experiment.Brown, A; Pain, T; Tan, A; Anable, L; Callander, E; Watt, K; Street, D; De Abreu Lourenco, R
2023-02-01Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors.Goldstein, DA; Ginsberg, GM; Hofnung-Gabbay, D; De Abreu Lourenco, R; Loong, HH; Goh, BC; Chan, KKW; Di Maio, M; Perrone, F; Hall, PS; Zer, A; Rosenbaum, E
2021-05-18Online, Group-Based Psychological Support for Adolescent and Young Adult Cancer Survivors: Results from the Recapture Life Randomized TrialSansom-Daly, UM; Wakefield, CE; Ellis, SJ; McGill, BC; Donoghoe, MW; Butow, P; Bryant, RA; Sawyer, SM; Patterson, P; Anazodo, A; Plaster, M; Thompson, K; Holland, L; Osborn, M; Maguire, F; O'Dwyer, C; De Abreu Lourenco, R; Cohn, RJ; The Recapture Life Working Party,
2017-12-01Patterns and drivers of health care use in long-term childhood cancer survivors: A systematic reviewvan Breeschoten, J; De Abreu Lourenco, R; Signorelli, C; Haas, M; Cohn, RJ; Wakefield, CE; Fardell, JE
2022-12Perceptions and recall of treatment for prostate cancer: A survey of two populations.Brown, A; Tan, A; Anable, L; Callander, E; De Abreu Lourenco, R; Pain, T
2017-07-11Predicting Infectious ComplicatioNs in Children with Cancer: An external validation studyHaeusler, GM; Thursky, KA; Mechinaud, F; Babl, FE; De Abreu Lourenco, R; Slavin, MA; Phillips, R
2022-10Preferences for a polygenic test to estimate cancer risk in a general Australian population.Venning, B; Saya, S; De Abreu Lourenco, R; Street, DJ; Emery, JD
2021-05-20Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile NeutropeniaDoerflinger, M; Haeusler, GM; Li-Wai-Suen, CSN; Clark, JE; Slavin, M; Babl, FE; Allaway, Z; Mechinaud, F; Smyth, GK; De Abreu Lourenco, R; Phillips, B; Pellegrini, M; Thursky, KA
2018-11-01A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocolHofman, MS; Murphy, DG; Williams, SG; Nzenza, T; Herschtal, A; De Abreu Lourenco, R; Bailey, DL; Budd, R; Hicks, RJ; Francis, RJ; Lawrentschuk, N
2020Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropeniaHaeusler, G; Thursky, K; Slavin, MA; Babl, FE; De Abreu Lourenco, R; Mechinaud, F; Phillips, B
2019-02-01Reviewing the cost-effectiveness of long-acting reversible contraceptive methods in an Australian contextLynch, M; De Abreu Lourenco, R; Flattery, M; Haas, M
2020-01-01Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rulesHaeusler, GM; Thursky, KA; Slavin, MA; Babl, FE; De Abreu Lourenco, R; Allaway, Z; Mechinaud, F; Phillips, R
2020Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and costFindlay, M; Brown, C; De Abreu Lourenco, R; White, K; Bauer, JD
2023-02-01SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors.Jefford, M; Emery, JD; Martin, AJ; De Abreu Lourenco, R; Lisy, K; Mohamed, MA; King, D; Tebbutt, NC; Lee, M; Mehrnejad, A; Burgess, A; Marker, J; Eggins, R; Carrello, J; Schofield, P
2023-12SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer.Jefford, M; Emery, JD; James Martin, A; De Abreu Lourenco, R; Lisy, K; Grunfeld, E; Mohamed, MA; King, D; Tebbutt, NC; Lee, M; Mehrnejad, A; Burgess, A; Marker, J; Eggins, R; Carrello, J; Thomas, H; Schofield, P
2017-10-30SCORE: Shared care of Colorectal cancer survivors: Protocol for a randomised controlled trialJefford, M; Emery, J; Grunfeld, E; Martin, A; Rodger, P; Murray, AM; De Abreu Lourenco, R; Heriot, A; Phipps-Nelson, J; Guccione, L; King, D; Lisy, K; Tebbutt, N; Burgess, A; Faragher, I; Woods, R; Schofield, P